Cargando…
Grabody B, an IGF1 receptor-based shuttle, mediates efficient delivery of biologics across the blood-brain barrier
Effective delivery of therapeutics to the brain is challenging. Molecular shuttles use receptors expressed on brain endothelial cells to deliver therapeutics. Antibodies targeting transferrin receptor (TfR) have been widely developed as molecular shuttles. However, the TfR-based approach raises conc...
Autores principales: | Shin, Jung-Won, An, Sungwon, Kim, Dongin, Kim, Hyunjoo, Ahn, Jinhyung, Eom, Jaehyun, You, Weon-Kyoo, Yun, Hyesu, Lee, Bora, Sung, Byungje, Jung, Jinwon, Kim, Sehyun, Son, Yonggyu, Sung, Eunsil, Lee, Hanbyul, Lee, Suyeon, Song, Daehae, Pak, Youngdon, Sandhu, Jagdeep K., Haqqani, Arsalan S., Stanimirovic, Danica B., Yoo, Jiseon, Kim, Donghwan, Maeng, Sungho, Lee, Jeonghun, Lee, Sang Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701613/ https://www.ncbi.nlm.nih.gov/pubmed/36452865 http://dx.doi.org/10.1016/j.crmeth.2022.100338 |
Ejemplares similares
-
N-terminal selective conjugation method widens the therapeutic window of antibody–drug conjugates by improving tolerability and stability
por: Ko, Min Ji, et al.
Publicado: (2021) -
Conformation-specific Antibodies Targeting Aggregated Forms of α-synuclein Block the Propagation of Synucleinopathy
por: Choi, Minsun, et al.
Publicado: (2022) -
ABL001, a Bispecific Antibody Targeting VEGF and DLL4, with Chemotherapy, Synergistically Inhibits Tumor Progression in Xenograft Models
por: Yeom, Dong-Hoon, et al.
Publicado: (2020) -
Novel anti-4-1BB×PD-L1 bispecific antibody augments anti-tumor immunity through tumor-directed T-cell activation and checkpoint blockade
por: Jeong, Seongju, et al.
Publicado: (2021) -
The Neuromodulation of Neuropathic Pain by Measuring Pain Response Rate and Pain Response Duration in Animal
por: Kim, Jinhyung, et al.
Publicado: (2015)